Tofacitinib Impurity T

• Description:

  Tofacitinib Impurity T (3- ((3R,4R) -4-Methyl-3- (methyl (7H-pyrrolo[2,3-d]pyrimidin-4-yl) amino) piperidin-1-yl) -3-oxopropanamide) is a drug intermediate for synthesis of various active compounds.

• Product Name Alternative:

  3- ((3R,4R) -4-Methyl-3- (methyl (7H-pyrrolo[2,3-d]pyrimidin-4-yl) amino) piperidin-1-yl) -3-oxopropanamide

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H315, H319, H335

• Target:

  Drug Intermediate

• Related Pathways:

  Others

• Field of Research:

  Others

• Purity:

  99.80

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(CC(N)=O)N1C[C@H](N(C2=C3C(NC=C3)=NC=N2)C)[C@H](C)CC1

• Molecular Formula:

  C16H22N6O2

• Molecular Weight:

  330.39

• Precautions:

  H302, H315, H319, H335

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound2

• Clinical Information:

  No Development Reported

• CAS Number:

  [1675248-19-7]